INTEROR Plans to Strengthen Partnership within India's Pharma Supply Chain

INREROR, the French company, is planning to strengthen ties with Indian pharmaceutical manufacturers.

Dr. Reddy's Plans Global GLP-1 Launch as Patents Expire

Dr. Reddy's Laboratories is preparing to enter the rapidly expanding GLP-1 (glucagon-like peptide-1) drug market, hoping to launch generic versions of key diabetes and obesity drugs such as Semaglutide...

CDSCO Approves Entod Pharma's Myopia-control Eye Drop for Children

The Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization to Entod Pharmaceuticals, a multinational research-driven ophthalmic firm, for a novel ocular formulation designed

PCI Pharma Expands with Acquisition of Ajinomoto Althea, US CDMO

PCI Pharma Services ("PCI") – an award-winning global contract development and manufacturing company (CDMO) specializing in cutting-edge biopharma therapies – is buying a full equity interest in...

IT-enabled Clinical Firm Thyrocare Technologies posts Net Profit of Rs. 21.70 Crores

After reporting a 22.05 percent increase in consolidated net profit to Rs. 21.70 crore in Q4 FY25 over Q4 FY24, and a 21.34 percent increase in operating revenue to Rs. 187.16 crore, Thyrocare Technologies saw a 15 percent spike to Rs. 884.20.

Aurobindo Pharma's Unit gets USFDA Approval for Cancer Drug

Aurobindo Pharma announced that it’s fully owned subsidiary Eugia Pharma Specialities Ltd has received the USFDA approval for manufacturing and marketing its generic equivalent of ...

Dr Reddy's, Lupin recall drugs in US over labeling, manufacturing flaws

The US health agency has announced that Lupin and Dr. Reddy's Laboratories are recalling items in the US market because of manufacturing and labeling mistakes, respectively.

Gene Solutions, Element Biosciences team up to boost global NGS tech

Element Biosciences, a business that democratizes access to cutting-edge life science solutions, and Singapore-based startup Gene Solutions, which specializes in advanced genetic testing, have formed a strategic partnership

Novo Nordisk to Stop Human Mixtard, Top-Selling Insulin in India

Novo Nordisk has decided to discontinue Human Mixtard—India’s largest-selling insulin—and several other key insulin products, potentially reshaping the country's Rs 5,000 crore insulin market. The action indicates a major shift in the diabetes care

NKP Pharma, Rockwell Automation to enhance regulatory compliance

Rockwell Automation, a provider of digital transformation and industrial automation technology, has teamed up with NKP Pharma, a pharmaceutical packaging machinery manufacturer in Gujarat, to introduce a new visualization solution that will enhance

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring